Clinical Trial Update: Rosiglitazone Versus Theophylline in Asthmatic Smokers [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial compared rosiglitazone with theophylline in asthmatic smokers and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Rosiglitazone (Avandia) (rosiglitazone)
• Theophylline (Theophylline)

Snippet

Sponsor: University of Glasgow | Conditions: Asthma | Phase 2, Phase 3 | Status: COMPLETED